Terms: = Cervical cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132
8 results:
1. Targeting the NRF2/keap1 pathway in cervical and endometrial cancers.
Tossetta G; Marzioni D
Eur J Pharmacol; 2023 Feb; 941():175503. PubMed ID: 36641100
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Correlates of Unfavorable Outcome in Locally Advanced cervical cancer Treated with Neoadjuvant Chemoradiation.
Wei Y; Wei C; Chen L; Liu N; Ou Q; Yin JC; Pang J; Fang Z; Wu X; Wang X; Mu D; Shao Y; Yu J; Yuan S
Cancer Res Treat; 2022 Oct; 54(4):1209-1218. PubMed ID: 35038823
[TBL] [Abstract] [Full Text] [Related]
3. Clinical significance of keap1 in cervical cancer.
Wang J; Li X; Zhou Y; Hong L
J BUON; 2021; 26(5):1809-1814. PubMed ID: 34761587
[TBL] [Abstract] [Full Text] [Related]
4. Combination of cyanidin-3-O-glucoside and cisplatin induces oxidative stress and apoptosis in HeLa cells by reducing activity of endogenous antioxidants, increasing bax/bcl-2 mRNA expression ratio, and downregulating Nrf2 expression.
Li X; Mu J; Lin Y; Zhao J; Meng X
J Food Biochem; 2021 Jul; 45(7):e13806. PubMed ID: 34080212
[TBL] [Abstract] [Full Text] [Related]
5. keap1/NRF2 signaling pathway mutations in cervical cancer.
Chu XY; Li ZJ; Zheng ZW; Tao YL; Zou FX; Yang XF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4458-4466. PubMed ID: 30058679
[TBL] [Abstract] [Full Text] [Related]
6. Functional Role of NRF2 in cervical Carcinogenesis.
Ma JQ; Tuersun H; Jiao SJ; Zheng JH; Xiao JB; Hasim A
PLoS One; 2015; 10(8):e0133876. PubMed ID: 26247201
[TBL] [Abstract] [Full Text] [Related]
7. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways.
Do MT; Kim HG; Khanal T; Choi JH; Kim DH; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2013 Sep; 271(2):229-38. PubMed ID: 23707609
[TBL] [Abstract] [Full Text] [Related]
8. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival.
Bachtiary B; Selzer E; Knocke TH; Pötter R; Obermair A
Cancer Lett; 2002 May; 179(2):197-203. PubMed ID: 11888674
[TBL] [Abstract] [Full Text] [Related]
